Memantine Therapy for Multiple Sclerosis

Summary

Memantine Therapy for Multiple Sclerosis is a clinical trial^[1].

Key Facts

• Memantine Therapy for Multiple Sclerosis is in the country of Spain^[2].
• Memantine Therapy for Multiple Sclerosis's instance of is recorded as clinical trial^[3].
• Memantine Therapy for Multiple Sclerosis's start time is recorded as +2007-09-30T00:00:00Z^[4].
• Memantine Therapy for Multiple Sclerosis's end time is recorded as +2008-03-31T00:00:00Z^[5].
• Memantine Therapy for Multiple Sclerosis's main subject is recorded as multiple sclerosis^[6].
• Memantine Therapy for Multiple Sclerosis's main subject is recorded as sclerosis^[7].
• Memantine Therapy for Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+20'}^[8].
• Memantine Therapy for Multiple Sclerosis's title is recorded as Pilot Clinical Trial With Memantine for Cognitive Deficits in Patients With Multiple Sclerosis^[9].
• Memantine Therapy for Multiple Sclerosis's short name is recorded as Memantine-MS^[10].
• Memantine Therapy for Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Memantine Therapy for Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT00638833^[12].
• Memantine Therapy for Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• Memantine Therapy for Multiple Sclerosis's research intervention is recorded as memantine^[14].
• Memantine Therapy for Multiple Sclerosis's clinical trial phase is recorded as phase II clinical trial^[15].
• Memantine Therapy for Multiple Sclerosis's research subject recruitment status is recorded as terminated^[16].
• Memantine Therapy for Multiple Sclerosis's study type is recorded as interventional study^[17].